Response to: Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'

Br J Cancer. 2015 Dec 1;113(11):1633-4. doi: 10.1038/bjc.2015.320. Epub 2015 Sep 8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Brain Neoplasms / drug therapy*
  • Dexamethasone / pharmacology*
  • Female
  • Glioblastoma / drug therapy*
  • Humans
  • Male
  • Neoplasm Recurrence, Local / drug therapy*

Substances

  • Dexamethasone